Webinar
Contents
Chair

Jean-François Dufour, MD
Director
Centre des maladies digestives, Lausanne, Switzerland.
Specialist in Internal Medicine, Gastroenterology and Hepatology.
Centre des maladies digestives, Lausanne, Switzerland.
Specialist in Internal Medicine, Gastroenterology and Hepatology.
Speaker(s)

Pompilia Radu, MD, PhD
Hepatology-Department of Biomedical Research, University of Bern, Bern, Switzerland; University Clinic for Visceral Surgery and Medicine, Inselspital, University of Bern, Bern, Switzerland.
Topic: What is the place of body composition assessment in HCC management?
Topic: What is the place of body composition assessment in HCC management?

Francesco Tovoli, MD, PhD
Senior assistant professor, Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.
Topic: Shall we recommend coffee consumption to patients at risk of liver cancer?
Topic: Shall we recommend coffee consumption to patients at risk of liver cancer?

Xuehong Zhang, MBBS, ScD
Assistant Professor in Medicine, Harvard Medical School; Assistant Professor in the Department of Nutrition, Harvard T. H. Chan School of Public Health; Associate Epidemiologist, Brigham and Women's Hospital; Co-Chair, Liver Cancer Task Force, Dana Farber Harvard Cancer Center.
Topic: Which diet shall we recommend to decrease the risk of HCC?
Topic: Which diet shall we recommend to decrease the risk of HCC?

Jean-François Dufour, MD
Director
Centre des maladies digestives, Lausanne, Switzerland.
Specialist in Internal Medicine, Gastroenterology and Hepatology.
Topic: Is it worth to recommend physical activity to decrease HCC risk?
Centre des maladies digestives, Lausanne, Switzerland.
Specialist in Internal Medicine, Gastroenterology and Hepatology.
Topic: Is it worth to recommend physical activity to decrease HCC risk?

Iulia Minciuna
Regional Institute of Gastroenterology and Hepatology Octavian Fodor, Romania.
Topic: Is fasting good when one is at risk of liver cancer?
Topic: Is fasting good when one is at risk of liver cancer?
Programme
Programme
- Time (Switzerland, UTC +1)
- Speakers
- Topics
- 14:00-14:10
- Chair(Jean-Francois Dufour)
- Welcome Remarks
- 14:10-14:25
- Francesco Tovoli
- Shall we recommend coffee consumption to patients at risk of liver cancer?
- 14:25-14:40
- Iulia Minciuna
- Is fasting good when one is at risk of liver cancer?
- 14:40-14:55
- Xuehong Zhang
- Which diet shall we recommend to decrease the risk of HCC?
- 14:55-15:15
- /
- Discussion Part 1
- 15:15-15:25
- /
- Break
- 15:25-15:40
- Jean-Francois Dufour
- Is it worth to recommend physical activity to decrease HCC risk?
- 15:40-15:55
- Pompilia Radu
- What is the place of body composition assessment in HCC management?
- 15:55-16:15
- /
- Discussion Part 2
- 16:15-16:25
- Chair(Jean-Francois Dufour)
- Concluding Remarks
Moments






Presentation

Francesco Tovoli, Senior assistant professor, Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.
Topic: Shall we recommend coffee consumption to patients at risk of liver cancer?
NaN

Iulia Minciuna, Regional Institute of Gastroenterology and Hepatology Octavian Fodor, Romania.
Topic: Is fasting good when one is at risk of liver cancer?
NaN

Xuehong Zhang, Assistant Professor in Medicine, Harvard Medical School; Assistant Professor in the Department of Nutrition, Harvard T. H. Chan School of Public Health; Associate Epidemiologist, Brigham and Women's Hospital; Co-Chair, Liver Cancer Task Force, Dana Farber Harvard Cancer Center.
Topic: Which diet shall we recommend to decrease the risk of HCC?
NaN

Jean-François Dufour, Director, Centre des maladies digestives, Lausanne, Switzerland. Specialist in Internal Medicine, Gastroenterology and Hepatology.
Topic: Is it worth to recommend physical activity to decrease HCC risk?
NaN

Pompilia Radu, Hepatology-Department of Biomedical Research, University of Bern, Bern, Switzerland; University Clinic for Visceral Surgery and Medicine, Inselspital, University of Bern, Bern, Switzerland.
Topic: What is the place of body composition assessment in HCC management?
NaN